These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35702096)

  • 1. Clinical value of prophylactic transcatheter arterial chemoembolization treatment in patients with hepatocellular carcinoma.
    Li H; Liu Z; Han C
    Am J Transl Res; 2022; 14(5):3225-3232. PubMed ID: 35702096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of postoperative antiviral combined transcatheter arterial chemoembolization therapy in prevention of hepatitis B-related hepatocellular carcinoma recurrence.
    Yan Q; Ni J; Zhang GL; Yao X; Yuan WB; Zhou L; Zheng SS
    Chin Med J (Engl); 2013 Mar; 126(5):855-9. PubMed ID: 23489790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TACE Combined with HIFU Versus Surgical Resection for Single Hepatocellular Carcinoma with Child-Pugh B Cirrhosis in Overall Survival and Progression-Free Survival: A Retrospective Study.
    Zhang Q; Wang Y; Zhang J; Zhang W; Gong J; Ma R
    Technol Cancer Res Treat; 2021; 20():15330338211060180. PubMed ID: 34855560
    [No Abstract]   [Full Text] [Related]  

  • 5. Transcatheter arterial chemoembolization combined with interferon-α is safe and effective for patients with hepatocellular carcinoma after curative resection.
    Zuo CH; Xia M; Liu JS; Qiu XX; Lei X; Xu RC; Liu HC; Li JL; Li YG; Li QL; Xiao H; Hong Y; Wang XH; Zhu HZ; Wu QF; Burns M; Liu C
    Asian Pac J Cancer Prev; 2015; 16(1):245-51. PubMed ID: 25640360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of traditional herbal medicine versus transcatheter arterial chemoembolization in postsurgical patients with hepatocellular carcinoma: A retrospective study.
    Xu X; Chen R; Chen Q; An K; Ding L; Zhang L; Wang F; Deng Y
    Complement Ther Clin Pract; 2021 May; 43():101359. PubMed ID: 33711747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Postoperative Adjuvant Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients with Mesenchymal Circulating Tumor Cell.
    Zhang J; Peng H; Wang B; Luo L; Cheng Y; He G; Tang Y; Pan M
    J Gastrointest Surg; 2021 Jul; 25(7):1770-1778. PubMed ID: 32748340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
    Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
    World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Appraisal of postoperative transcatheter arterial chemoembolization (TACE) for prevention and treatment of hepatocellular carcinoma recurrence].
    Lin Z; Ren Z; Xia J
    Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):315-7. PubMed ID: 11778559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventive effects of jiedu granules combined with cinobufacini injection versus transcatheter arterial chemoembolization in post-surgical patients with hepatocellular carcinoma: a case-control trial.
    Chen Z; Chen HY; Lang QB; Li B; Zhai XF; Guo YY; Yue XQ; Ling CQ
    Chin J Integr Med; 2012 May; 18(5):339-44. PubMed ID: 22549390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant transcatheter arterial chemoembolization after radical resection of hepatocellular carcinoma patients with tumor size less than 5 cm: a retrospective study.
    Lazuardi F; Valencia J; Zheng S
    Scand J Gastroenterol; 2019 May; 54(5):617-622. PubMed ID: 31079496
    [No Abstract]   [Full Text] [Related]  

  • 12. The Clinical Value of Postoperative Transarterial Chemoembolization for Resectable Patients with Intermediate Hepatocellular Carcinoma After Radical Hepatectomy: a Propensity Score-Matching Study.
    Wang L; Lin N; Lin K; Xiao C; Wang R; Chen J; Zhou W; Liu J
    J Gastrointest Surg; 2021 May; 25(5):1172-1183. PubMed ID: 32440804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of Benefit of Transcatheter Arterial Chemoembolization (TACE) in Patients with Resectable Solitary Hepatocellular Carcinoma.
    Ha TY; Hwang S; Lee YJ; Kim KH; Ko GY; Ii Gwon D; Ahn CS; Moon DB; Song GW; Jung DH; Lee HC; Lim YS; Kim KM; Shim JH; Choi JH; Lee SG
    World J Surg; 2016 May; 40(5):1200-10. PubMed ID: 26666422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of prophylactic TACE on 5-year survival of patients with hepatocellular carcinoma after hepatectomy.
    He S; Fan X; Ma H; Xiaerfuhazi H; Rehato A; Feng J; Shi X; He F
    Oncol Lett; 2019 Aug; 18(2):1824-1830. PubMed ID: 31423250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of transcatheter arterial chemoembolization in the prevention of postoperative recurrence in 1630 patients with hepatocellular carcinoma].
    Cheng HY; Xu W; Xu AM; Chen D; Yang YF; Jia YC
    Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):626-8. PubMed ID: 16438876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined transcatheter arterial chemoembolization and radiofrequency ablation in single-session for solitary hepatocellular carcinoma larger than 7 cm.
    Yan JY; Zhang JL; Wang MQ; Yuan K; Bai YH; Wang Y; Xin HN; Wang ZJ; Liu FY; Duan F; Fu JX
    Asia Pac J Clin Oncol; 2018 Aug; 14(4):300-309. PubMed ID: 29124894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of transcatheter arterial chemoembolization after radiofrequency ablation as a combined therapy for Chinese patients with hepatocellular carcinoma.
    Xu RC; Liu HC; Li JL; Li K; Ou SY; Yu ZY; Kong Y; Ma GA; Shao WS
    Curr Med Res Opin; 2015 Aug; 31(8):1553-60. PubMed ID: 26067770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysis.
    Li C; Wang MD; Lu L; Wu H; Yu JJ; Zhang WG; Pawlik TM; Zhang YM; Zhou YH; Gu WM; Wang H; Chen TH; Han J; Xing H; Li ZL; Lau WY; Wu MC; Shen F; Yang T
    Hepatol Int; 2019 Nov; 13(6):736-747. PubMed ID: 31486964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofrequency ablation combined with transcatheter arterial chemoembolization for the treatment of single hepatocellular carcinoma of 2 to 5 cm in diameter: comparison with surgical resection.
    Kim JW; Shin SS; Kim JK; Choi SK; Heo SH; Lim HS; Hur YH; Cho CK; Jeong YY; Kang HK
    Korean J Radiol; 2013; 14(4):626-35. PubMed ID: 23901320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
    Zhao M; Wang JP; Li W; Huang ZL; Zhang FJ; Fan WJ; Zhang L; Li XS; Pan CC; Wu PH
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1167-72. PubMed ID: 21756768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.